Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
21 hedge funds and large institutions have $311K invested in Celgene Corporation Contingent Value Rights in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
11% more funds holding
Funds holding: 19 → 21 (+2)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
69% less capital invested
Capital invested by funds: $1.02M → $311K (-$707K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.3K |
| 2 |
BFA
Beaumont Financial Advisors
Needham,
Massachusetts
|
+$9.83K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$679 |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$49 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
-$32.8K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.6K |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$164 |
| 5 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$104 |
CELGZ Hedge Fund Activity: Q1 2018 in Review
21 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q1 2018, worth a combined $311K — down 69% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CELGZ positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.3K. The largest seller was Birchview Capital, cutting an estimated $32.8K.
- 21 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q1 2018, up from 19 in Q4 2017.
- Funds reported $311K of Celgene Corporation Contingent Value Rights stock for Q1 2018, down 69% quarter-over-quarter.
- 3 funds opened new Celgene Corporation Contingent Value Rights positions in Q1 2018 and 1 closed out, a net change of +2 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q1 2018 was Citadel Advisors, an estimated $21.3K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q1 2018 was Birchview Capital, an estimated $32.8K sold.
Based on aggregated 13F filings for Q1 2018.